Good for you Craig… that you can keep the door open for
Good for you Craig… that you can keep the door open for the 13d group. I am way past all the misinformation and out right lies that have been pushed by the bashers who I believe are more than just average stock holders. I am sure we have many paid basher pushing their agenda not just here but on all social media and chat boards. This is a big production that they have tried to accomplish. I feel that they were coarse and abrasive and just didn’t function in a way that garnered enough support. I think they have failed in their bid to take over the company. This proxy card that I don’t remember the color of will let them know in a day or so that they have ultimately failed.
This deception and effort of the 13d group doesn’t bode well. It just wont matter what the can provide as a plan for me now that I would even consider changing sides. It’s just to late for them to bring something to the table that would be worthy. They have shown their true colors and honesty isn’t one attribute they have. They just don’t have anything I would be excited about. Their leadership from top to bottom isn’t impressive and lack any experience needed in a biotech. Last I checked we are a biotech and the 13d people that might have some experience were former employees that sued us and cost us millions. Just the wrong type of people to put forward as someone we need or want. Are these former employees looking for revenge?
I feel that the 13d group has put hate as their number one priority to inflict on our company and that’s just not ok. It’s not ok to push a bashing agenda and be rewarded with followers. People are not fooled by such terrible actions. Nobody aspires to be a basher and hopes to be liked for it. We can’t take a chance on an inexperienced new management that is clueless to everything going on with partnerships and relationships with people all over the world and will take many months to get up to speed figure it all out. Now is not the time to allow a new group to take the reins on a company on the cusp of great things.
There is so many positive catalysts happening in the next few months. I feel fortunate to be invested in this company and see the growth of this management to learn the lessons they have and apply the knowledge to the new trials. We are almost there and don’t need any help to get there. Especially from a group I wouldn’t trust them as far as I could throw them.
Everyone should really ask themselves who is more trust worthy? A management with a plan to trial 10 indications a year and grow into our own big Pharma or a group that doesn’t have a plan. Won’t show us a plan and never had a plan they would ever show us. It’s really quite scary and not very genuine to believe someone that has no apparent leadership or direction to show us something now. Our management has been straight forward and left no doubt in their plan or their new presentation. I approve of our current direction and future direction and see great things happening. Why take a chance on a group that could screw us over. That just doesn’t make sense. I won’t trust someone like the 13d group with my money. They have done nothing to impress us or do we expect them to. The big issue here is trust… who has earned my trust. I can tell you I have absolutely no trust in the 13d group.
16
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...
Continue Reading
Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....
Continue Reading
Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...
Continue Reading
A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...
Continue Reading
Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...
Continue Reading
Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...
Continue Reading
Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...
Continue Reading
By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...
Continue Reading
Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...
Continue Reading
Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...
Continue Reading
Top 5 Most Recently Viewed Articles
Valneva SE's Ixchiq Vaccine Under Scrutiny Valneva SE stock (VALN) experienced a decline recently after the U.S. Food and Drug Administration (FDA) announced the suspension of its license for the Ixchiq vaccine. This decision stems from reports of serious adverse events (SAEs) linked to chikungunya-like illness, leading to concerns about the vaccine's safety profile....
Continue Reading
Tetra Tech Selected for £800 Million Water Management Framework In a significant development, Tetra Tech, Inc. (NASDAQ: TTEK), a prominent provider of advanced consulting and engineering services, has been awarded a major contract by Northern Ireland Water. This framework agreement, valued at up to £800 million, aims to bolster the sustainable delivery of essential...
Continue Reading
Synedgen Achieves Major Milestone with JWMRP Funding Synedgen, Inc., a prominent biotechnology firm, is making headlines with its recent announcement about receiving a substantial $2.2 million contract from the Joint Warfighter Medical Research Program (JWMRP). This funding is designated for the advancement of MIIST305, a pioneering therapeutic aimed at shielding...
Continue Reading
Ensurge Micropower ASA Extends Private Placement Bookbuilding Ensurge Micropower ASA has recently made waves in the investment community with an update on its ongoing private placement. The company is taking strategic steps to extend the bookbuilding period, offering investors increased opportunities to participate. The update was shared following a stock exchange...
Continue Reading
Dale Hageman to Lead ESAC Board as Chairman Spirit HR is proud to share that its CEO and Founder, Dale Hageman, has been elected Chairman of the Board for the Employer Services Assurance Corporation (ESAC). This leadership role reflects Dale’s long-standing dedication to the HR field and his steady commitment to the highest levels of financial assurance and...
Continue Reading